Jpmorgan Healthcare Leaders ETF Rating $52.39 -0.24 (-0.46%) As of 04/3/2025 03:29 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Jpmorgan Healthcare Leaders ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.JDOC Aggregate RatingModerate Buy 2.77Holdings in JDOC have an aggregate rating of Moderate Buy based on 696 analyst ratings issued in the past year covering 38 companies (75.1% of the portfolio).JDOC Aggregate Price Target$52.39High Prediction$52.39Average Prediction$52.39Low Prediction$52.39Holdings in JDOC have an aggregate price target of $52.39 and a range of $52.39 to $52.39 covering 38 companies (75.1% of the portfolio).JDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Jpmorgan Healthcare Leaders ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 JDOC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.70%LLYEli Lilly and Company$788.62-3.6%4.9178 of 5 stars2.84$1,009.72 28.0%198.09%UNHUnitedHealth Group$540.87+3.4%4.8783 of 5 stars3.10$629.32 16.4%21Positive News6.54%JNJJohnson & Johnson$159.90+2.9%4.2204 of 5 stars2.56$171.33 7.2%18Analyst ForecastOptions VolumeGap Up4.67%ABBVAbbVie$201.31-1.9%4.4562 of 5 stars2.92$211.45 5.0%25Insider TradePositive NewsGap Up3.77%BMYBristol-Myers Squibb$57.71-3.2%3.7945 of 5 stars2.33$57.86 0.3%18Short Interest ↑Analyst RevisionPositive News3.73%BSXBoston Scientific$98.51-1.5%4.5794 of 5 stars3.00$108.91 10.6%23Options VolumePositive NewsGap Down3.48%MDTMedtronic$87.89-1.1%4.2846 of 5 stars2.44$96.07 9.3%16Positive News3.19%VRTXVertex Pharmaceuticals$484.01+0.1%3.7342 of 5 stars2.65$509.17 5.2%26Analyst ForecastPositive News2.91%SYKStryker$368.12-2.5%4.7087 of 5 stars2.80$421.90 14.6%20Ex-DividendPositive NewsHigh Trading Volume2.88%MCKMcKesson$716.71+3.3%4.35 of 5 stars2.93$661.00 -7.8%15Analyst ForecastAnalyst RevisionNews CoveragePositive NewsHigh Trading Volume2.86%DHRDanaher$197.75-3.6%4.9295 of 5 stars2.81$278.24 40.7%21Positive News2.15%CVSCVS Health$67.44-0.9%4.8647 of 5 stars2.90$70.41 4.4%21Positive NewsGap Down2.12%TMOThermo Fisher Scientific$469.88-3.9%4.8719 of 5 stars2.82$653.23 39.0%22Positive News1.86%REGNRegeneron Pharmaceuticals$610.64-2.4%4.758 of 5 stars2.76$966.88 58.3%25Short Interest ↑Analyst RevisionPositive News1.85%ISRGIntuitive Surgical$494.61-2.5%4.5373 of 5 stars2.67$611.86 23.7%21Positive NewsGap Down1.33%HCAHCA Healthcare$349.03+0.6%4.9395 of 5 stars2.83$385.67 10.5%18Short Interest ↓Positive News1.25%VEEVVeeva Systems$221.58-2.2%4.4727 of 5 stars2.52$256.52 15.8%25Insider TradePositive News1.24%ZBHZimmer Biomet$112.72+0.2%4.6843 of 5 stars2.32$124.15 10.1%22Positive News1.22%AAgilent Technologies$109.63-5.5%4.3121 of 5 stars2.46$150.83 37.6%13Ex-DividendInsider TradePositive NewsGap DownHigh Trading Volume1.13%IQVIQVIA$167.62-3.9%4.7443 of 5 stars2.86$249.05 48.6%21Positive News1.05%CAHCardinal Health$136.96-1.2%4.4573 of 5 stars2.71$140.14 2.3%14Analyst ForecastAnalyst RevisionPositive News0.84%HALOHalozyme Therapeutics$61.92-1.7%4.1815 of 5 stars2.60$62.78 1.4%10Positive News0.76%COOCooper Companies$78.17-3.8%3.2329 of 5 stars2.70$110.25 41.0%10Short Interest ↑Analyst Revision0.74%AMGNAmgen$309.85+1.4%4.3592 of 5 stars2.48$314.04 1.4%23Positive News0.66%PENPenumbra$272.91-1.6%4.3293 of 5 stars2.88$294.47 7.9%17Insider TradeGap Down0.64%NTRANatera$138.71-3.1%3.7215 of 5 stars3.00$178.12 28.4%16Insider TradePositive NewsGap Down0.54%BPMCBlueprint Medicines$87.11-3.2%2.7386 of 5 stars2.70$124.95 43.4%23News CoveragePositive NewsGap Down0.51%ALKSAlkermes$31.66-3.0%4.5381 of 5 stars2.69$39.38 24.4%130.49%NBIXNeurocrine Biosciences$102.88-5.0%4.8513 of 5 stars2.83$165.38 60.8%23Positive NewsGap Down0.47%ASNDAscendis Pharma A/S$150.09-1.4%3.023 of 5 stars2.93$204.64 36.3%14Positive NewsGap Down0.42%RVMDRevolution Medicines$32.87-5.0%4.1245 of 5 stars3.08$65.23 98.5%13Analyst ForecastPositive NewsGap Down0.40%AGIOAgios Pharmaceuticals$27.71-2.6%4.2601 of 5 stars2.56$56.57 104.2%9Short Interest ↓News CoveragePositive NewsGap Down0.37%TWSTTwist Bioscience$37.50-1.9%3.938 of 5 stars2.70$54.10 44.3%10Positive NewsGap Down0.30%EXASExact Sciences$44.28-0.6%4.4175 of 5 stars2.90$70.26 58.7%210.30%BHVNBiohaven$20.52-13.3%4.0816 of 5 stars3.07$62.77 205.8%15Gap DownHigh Trading Volume0.26%SRPTSarepta Therapeutics$58.61-6.2%4.7886 of 5 stars2.83$163.18 178.4%23Quiet Period ExpirationNews CoverageGap UpHigh Trading Volume0.25%XENEXenon Pharmaceuticals$30.71-2.4%2.3452 of 5 stars3.00$57.38 86.8%9Options VolumeNews CoverageGap DownHigh Trading Volume0.13%MRKMerck & Co., Inc.$86.32-0.3%5 of 5 stars2.65$117.12 35.7%23Analyst RevisionGap Up This page (NYSEARCA:JDOC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jpmorgan Healthcare Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Jpmorgan Healthcare Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
